Related Experiment Video
Updated: Aug 21, 2026

Multimodality Diagnosis of Mesenteric Ischemia
Published on: July 21, 2023
[Intestinal malperfusion in critical care patients]
G Knichwitz1, C Kruse, H van Aken
1Klinik für Anästhesiologie und operative Intensivmedizin, Universitätsklinikum Münster. knichwi@uni-muenster.de
Abstract:
Due to the bowel's poor tolerance of hypoxia, intestinal malperfusion presents as a grave disease with high mortality. The intensivist is confronted with this condition in association with other underlying diseases, in the course of surgery, during application of medication or associated with invasive therapy. In a critical care setting, the non-occlusive mesenteric ischemia (NOMI) is of increasing importance. Since critical care patients often lack clinical symptoms, special attention is required and one main factor of the patient's prognosis is early diagnosis. This review summarizes pathophysiology and diagnostic aspects and the range of therapeutic and preventive measures.
Insights
Intestinal malperfusion, including non-occlusive mesenteric ischemia (NOMI), is a severe condition requiring early diagnosis in critical care. This review covers its pathophysiology, diagnosis, and management strategies for better patient outcomes.
Area of Science:
- Gastroenterology and Critical Care Medicine
- Pathophysiology of Ischemic Conditions
Context:
- Intestinal malperfusion is a critical illness with high mortality, often complicating other diseases, surgery, or invasive therapies.
- Non-occlusive mesenteric ischemia (NOMI) is increasingly significant in intensive care settings.
- Critical care patients may present with subtle or absent clinical symptoms, necessitating heightened vigilance.
Purpose:
- To review the pathophysiology of intestinal malperfusion and non-occlusive mesenteric ischemia (NOMI).
- To discuss diagnostic challenges and methods for early detection in critically ill patients.
- To outline therapeutic and preventive strategies for managing intestinal malperfusion.
Summary:
- Intestinal malperfusion, exacerbated by the bowel's sensitivity to hypoxia, poses a grave threat, particularly NOMI in critical care.
- Early diagnosis is crucial for prognosis, as clinical signs can be obscured in critically ill patients.
- The review synthesizes current knowledge on the mechanisms, detection, and management of this condition.
Impact:
- Improved understanding of NOMI pathophysiology aids in developing targeted diagnostic and therapeutic approaches.
- Emphasis on early diagnosis can lead to timely intervention, potentially reducing mortality rates.
- Comprehensive review provides a valuable resource for intensivists managing patients at risk of intestinal malperfusion.
Related Concept Videos
Intestinal Obstruction II: Pathophysiology
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...

